Atlas Trials

Efficacy and Safety Assessment of Beltavac® With Polymerized Extract of HDM

Clinical trial NCT05395689 · UNKNOWN

Trial details

NCT number
NCT05395689
Sponsor
Probelte Pharma S.L.U.
Status
UNKNOWN
Phase
Phase 3
Study type
INTERVENTIONAL
House Dust Mite Allergy
Start date
2022-01-17
Primary completion
2026-06-01
Enrollment
350

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.